Filtered By:
Source: Circulation: Cardiovascular Quality and Outcomes

This page shows you your search results in order of date. This is page number 6.

Order by Relevance | Date

Total 429 results found since Jan 2013.

Abstract 195: Statin Use and Its Facility Level Variation in Patients With Ischemic Cerebrovascular Disease: Insights From the Department of Veterans Affairs Session Title: Poster Session II
Conclusions: The use of statin and especially guideline-recommended statin intensity is suboptimal in ICVD patients, especially patients without concomitant IHD or PAD. There is significant facility-level variation in receipt of guideline directed statin therapy in ICVD patients. Interventions are needed to improve guideline directed moderate to high-intensity statin use and reduce variation in care in this high risk group.
Source: Circulation: Cardiovascular Quality and Outcomes - March 31, 2017 Category: Cardiology Authors: McBride, C. L., Akaroyd, J., Ramsey, D. J., Nambi, V., Nasir, K., Michos, E. D., Birtcher, K. K., Morris, P. B., Bittner, V. A., Ballentyne, C. M., Peterson, L. A., Virani, S. S. Tags: Session Title: Poster Session II Source Type: research

Abstract 200: Is Risk-standardized In-hospital Stroke Mortality an Adequate Proxy for Risk-standardized 30-day Stroke Mortality Data? Findings From the GWTG-Stroke Program Session Title: Poster Session II
Conclusions: When used to identify outlier hospitals with high or low ischemic stroke mortality the agreement between in-hospital mortality and 30-day mortality was only modest. Using in-hospital mortality data proved to be a poor proxy for 30-day mortality.
Source: Circulation: Cardiovascular Quality and Outcomes - March 31, 2017 Category: Cardiology Authors: Reeves, M. J., Fonarow, G. C., Xu, H., Matsouaka, R., Xian, Y., Saver, J., Schwamm, L. H., Smith, E. E. Tags: Session Title: Poster Session II Source Type: research

Abstract 211: Implications of the PEGASUS-TIMI 54 Trial for U.S. Clinical Practice Session Title: Poster Session II
Conclusions: In contemporary clinical practice, a minority of patients are on a P2Y12inhibitor beyond 1-year post-MI. Applying PEGASUS trial findings to clinical practice would result in a large increase in P2Y12 inhibitor use with a cost per ischemic event averted that is strongly influenced by the choice of therapy.
Source: Circulation: Cardiovascular Quality and Outcomes - March 31, 2017 Category: Cardiology Authors: Bradley, S. M., Hess, G., Stewart, P., Armstrong, E., Farmer, S., Wasfy, J., Valle, J., Sandhu, A., Maddox, T. Tags: Session Title: Poster Session II Source Type: research

Abstract 218: Expanding a Learning Collaborative Model in Chicago to Improve Door to Needle for Stroke Thrombolysis: Raising the Bar Session Title: Poster Session II
Conclusions: Using a learning collaborative model to implement strategies to reduce DTN times among 24 Chicago area hospitals continues to impact times. Regional collaboration, data sharing, and best practice sharing should be a model for rapid and sustainable system-wide quality improvement.
Source: Circulation: Cardiovascular Quality and Outcomes - March 31, 2017 Category: Cardiology Authors: Prabhakaran, S., Sednew, R. M., ONeill, K. Tags: Session Title: Poster Session II Source Type: research

Abstract 219: Interdisciplinary Education and Relationship Building Improve Communication and Coordination in Stroke Care Session Title: Poster Session II
Conclusion: Through providing education to EMS providers and building relationships between EMS and hospitals, there has been a significant increase in pre-notification by EMS therefore improving timeliness of CT scans in acute stroke patients.
Source: Circulation: Cardiovascular Quality and Outcomes - March 31, 2017 Category: Cardiology Authors: Thorson, S., Sather, J., Alexander, J., Cook, M. Tags: Session Title: Poster Session II Source Type: research

Abstract 222: Use of a Decision Support Tool for Ischemic Stroke Treatment in a Telehealth System Session Title: Poster Session II
Conclusions: The preliminary results showed the rural hospital providers saw value in the RESOLVE tool while discussing the risks and benefits with patient/family. Future strategies would include process changes to expedite the faxing of the RESOLVE tool.
Source: Circulation: Cardiovascular Quality and Outcomes - March 31, 2017 Category: Cardiology Authors: Summers, D., Gialde, E., Spertus, J. A., Decker, C. Tags: Session Title: Poster Session II Source Type: research

Abstract 223: Impact of Differences in Once- vs Twice-Daily Medications Adherence on the Risk of Bleed and Stroke in Non-Valvular Atrial Fibrillation: Analysis of Randomized Trials and Claims Data Sources Session Title: Poster Session II
Conclusion: Among NVAF patients, better adherence to QD dosing was associated with a significantly lower stroke risk of QD but similar risk of bleed.
Source: Circulation: Cardiovascular Quality and Outcomes - March 31, 2017 Category: Cardiology Authors: McHorney, C. A., Peterson, E. D., Durkin, M., Ashton, V., Laliberte, F., Crivera, C., Sheikh, N., Germain, G., Schein, J. R., Xiao, Y., Lefebvre, P. Tags: Session Title: Poster Session II Source Type: research

Abstract 226: Strokes Worse in Women at 24 hours but Severity Reduced in Younger Women With Hormone Therapy Session Title: Poster Session II
Conclusion: Women in this study had more severe 24 hour AIS outcomes than men but this improved with HRT use in women younger than 80 years. This cannot be fully explained by age differences as there could be other underlying factors. Improving 24 hour NIHSS may correctly predict later outcomes following AIS. Further study of HRT use in AIS outcomes is justified.
Source: Circulation: Cardiovascular Quality and Outcomes - March 31, 2017 Category: Cardiology Authors: Brown, A., Onteddu, S., Joiner, R., Benton, T., Culp, W., Lowery, C. Tags: Session Title: Poster Session II Source Type: research

Abstract 231: Single Site Lifestyle Survey in FMD Patients Suggests Improvement Over Time Session Title: Poster Session II
Conclusion: Among patients from a single center participating in the USRFMD, rates of anxiety and depression are nearly double that of the general population. Trends indicate that depression, physical symptoms, and anxiety may decrease over time. Given the higher rates of anxiety, depression, and somatoform symptoms compared to the general population, greater efforts are needed to make earlier diagnoses and support patients, particularly in the early stages post-diagnosis.
Source: Circulation: Cardiovascular Quality and Outcomes - March 31, 2017 Category: Cardiology Authors: Bumpus, S. M., Heidt, S. T., Krallman, R., Kline-Rogers, E. Tags: Session Title: Poster Session II Source Type: research

Abstract 234: Participation in a Virtual Community and Its Impact on Quality of Life and Perceived Support Session Title: Poster Session II
Conclusions: Virtual networks are an evolving and a useful way to engage people. Understanding whether patients, loved ones, and caregivers perceive support, experience improved QOL after participation in, and are satisfied with a virtual community experience may provide evidence to inform ongoing development of the SN and confirm its value to these individuals. We found significant improvement in support and broad satisfaction with such an experience. More research is needed on the impact of virtual support networks.
Source: Circulation: Cardiovascular Quality and Outcomes - March 31, 2017 Category: Cardiology Authors: Khan, Y., Grady, K., Braun, L., Groom, A., Bahn, K. Tags: Session Title: Poster Session II Source Type: research

Abstract 159: Evaluation of Clinical Outcomes among Nonvalvular Atrial Fibrillation Patients Treated With Warfarin or Rivaroxaban Stratified by Presence or Absence of CKD in a Claims Database Session Title: Poster Session II
Conclusions: This study suggests that, in an adult population with NVAF, rivaroxaban-treated patients had fewer ischemic strokes across all patients, including patients with renal impairment. Rivaroxaban-treated patients also had significantly better outcomes for the composite (VTE, MI, or stroke) measure across all groups. Bleeding rates were comparable across all groups.
Source: Circulation: Cardiovascular Quality and Outcomes - March 31, 2017 Category: Cardiology Authors: Weir, M. R., Haskell, L., Berger, J. S., Ashton, V., Laliberte, F., Crivera, C., Brown, K., Lefebvre, P., Schein, J. Tags: Session Title: Poster Session II Source Type: research

Abstract 160: Impact of Medication Adherence on Risk of Stroke, Major Bleeding and Other Outcomes in Atrial Fibrillation Patients Using Novel Oral Anticoagulants (Dabigatran and Rivaroxaban) Session Title: Poster Session II
Conclusion: In our sample, adherence to NOACs was associated with a reduction in stroke and DVTPE risk but did not substantially increase bleeding risk. Further studies with newer NOACs are warranted.
Source: Circulation: Cardiovascular Quality and Outcomes - March 31, 2017 Category: Cardiology Authors: Deshpande, C. G., Willey Temkin, C., Laforge, R., Kogut, S. Tags: Session Title: Poster Session II Source Type: research

Abstract 161: Lean Process Improvements Reduce Door to CT and Door to Needle Times for Acute Ischemic Stroke Patients Session Title: Poster Session II
Conclusions: Lean process improvement methodology significantly reduces door to CT and door to needle times, supporting current AHA Target: Stroke goals and allowing faster treatment of patients with acute ischemic stroke. Incorporating time-outs into standardized processes that aim to deliver care more quickly may improve patient safety without substantially slowing down DTN times. Further investigation is required to determine whether the new process improved safety and clinical outcomes.
Source: Circulation: Cardiovascular Quality and Outcomes - March 31, 2017 Category: Cardiology Authors: McCann, C., Tkach, A., de Havenon, A., Loosli, J., Troyer, J., Bennett, A., Wold, J., Jex, A., Majersik, J. J. Tags: Session Title: Poster Session II Source Type: research

Abstract 171: Improving Adherence to Antihypertensive Agents for Hypertensive Patient With Chronic Kidney Disease Session Title: Poster Session II
Conclusions: Good MA is associated with a greater controlled hypertension, better protection of heart and kidney and may decrease mortality than the poor MA.
Source: Circulation: Cardiovascular Quality and Outcomes - March 31, 2017 Category: Cardiology Authors: Li, Y., Zeng, X., Zeng, X., Xie, J. Tags: Session Title: Poster Session II Source Type: research

Abstract 176: Door to Needle Targets in the Real World: A Dynamic Statistical Tool for Institutional Stroke Code Metrics Session Title: Poster Session II
Conclusions: This simple statistical tool is a novel solution for generating an institution-specific goal DTN based on unique organizational data, experiences, and nuances in order to meet the recommended mean DTN. Additionally, these individualized goals may further motivate stroke teams to carry out more efficient clinical care rather than consistently aiming for DTN values < 60 minutes. The tool presented here is easily adaptable to future changes in recommended target goals and can be seamlessly incorporated into institution-wide systems planning.
Source: Circulation: Cardiovascular Quality and Outcomes - March 31, 2017 Category: Cardiology Authors: Andrew, B. Y., Ehrlich, M. E., Stack, C. M., Yang, J. P., Dodds, J. A. Tags: Session Title: Poster Session II Source Type: research